What is the Envisia classifier?

A genomic test to help differentiate pulmonary fibrosis from other forms of interstitial lung disease

The test detects a pattern called UIP (usual interstitial pneumonia) that is associated with forms of scarring in your lungs. This pattern may be seen with IPF (idiopathic pulmonary fibrosis) or other types of interstitial lung disease.


The Envisia test result can help your doctor make a more confident diagnosis and treatment plan. Talk to your doctor about whether or not Envisia testing is right for you.

Patient Brochure

This handout may help healthcare professionals discuss the Envisia classifier with patients and how the test works.

Find a doctor for the Envisia test

To find a doctor in your area who performs the Envisia test, simply fill out the information form here. You will receive an email shortly with a list of practices in your area that offer the Envisia test.


Please note that the ILD experts in each practice will conduct a clinical evaluation which may or may not involve use of the Envisia classifier. It will be up to the clinical judgement of the physician to determine the appropriate diagnostic workup.

Patient Name:*
Patient Email:*
Patient Zip Code:*

Patient Resources

Play Video

Watch video to learn more

Hear Dr. Bulman discuss the role of Envisia in interview with PF warriors.

Play Video

Hear from a patient

Questions to ask your 
doctor about diagnosing Pulmonary Fibrosis

Veracyte Access Program

Because our testing may resolve important medical decisions, Veracyte is committed to providing all patients with access to our innovative and actionable genomic tests.


  • For Medicare patients, there is no copayment 
  • For privately insured patients, copay is determined by the individual plan 
  • The Veracyte Access Program provides financial support for both uninsured and commercially insured patients with financial need 

If you have any questions regarding your Veracyte bill, insurance Explanation of Benefits (EOB) or eligibility, please contact a Veracyte Customer Care representative rather than your healthcare provider.


844.464.LUNG (844.464.5864) or

The Envisia Genomic Classifier is available in the US as part of Veracyte’s CLIA-validated laboratory developed test (LDT) service. This test has not been cleared or approved by the FDA.


This website contains information on products that are targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for you accessing such information that may not comply with any legal process, regulation, registration or usage in the country of your origin.

© 2023 Veracyte, Inc. All rights reserved.


6000 Shoreline Court, Suite 300 

South San Francisco, CA 94080

163 Avenue de Luminy
13009 Marseille

6925 Lusk Boulevard, Suite 200
San Diego, CA 92121

12357-A Riata Trace Parkway
Building 5, Suite 100

Austin, TX 78727